Characteristics of clinical practice guidelines included in analysis
| Guideline producer | Year | Guideline type | Population | Scope |
|---|---|---|---|---|
| Government-sponsored guideline organizations (n = 3) | ||||
| Canadian Task Force on Preventive Health Care41 | 2018 | Screening | Pregnant women not at increased risk for asymptomatic bacteriuria | Screening for asymptomatic bacteriuria in pregnancy |
| Committee to Advise on Tropical Medicine and Travel42 | 2016 | Screening and drug management | Individuals with or at risk of disseminated strongyloidiasis | Prevention, assessment and management of disseminated strongyloidiasis |
| National Advisory Committee on Immunization, Public Health Agency of Canada43 | 2018 | Drug management | Adults and children | Influenza vaccination |
| Disease or condition interest groups (n = 9) | ||||
| Canadian ADHD Resource Alliance44 | 2018 | Screening and drug management | Patients with ADHD | Diagnosis and management of ADHD |
| Canadian HIV Trials Network45 | 2017 | Drug management | Adults who are at risk of acquiring HIV infection through sexual activity or injection drug use | HIV pre-exposure prophylaxis and non-occupational postexposure prophylaxis |
| Canadian Network for Mood and Anxiety Treatments46 | 2016 | Drug management | Adults with unipolar major depressive disorder | Management of major depressive disorder (pharmacologic treatments) |
| Canadian Research Initiative in Substance Misuse47 | 2018 | Drug management | Adults with opioid use disorders | Management of opioid use disorders |
| Diabetes Canada48 | 2018 | Drug management | Patients with diabetes | Prevention and management of cardiovascular disease |
| Heart and Stroke Foundation of Canada49 | 2018 | Screening and drug management | Children and adults with transient ischemic attack or ischemic stroke who are not candidates for immediate hyperacute thrombolysis treatment with intravenous alteplase or endovascular thrombectomy | Prevention of ischemic stroke recurrence through identification and management of modifiable vascular risk factors |
| Hypertension Canada50 | 2018 | Drug management | Pregnant women with hypertension | Management of hypertension in pregnancy |
| Kidney Cancer Research Network of Canada51 | 2017 | Screening and drug management | Patients with advanced kidney cancer | Management of advanced kidney cancer |
| Thrombosis Canada52 | 2016 | Drug management | Patients with deep vein thrombosis | Treatment of deep vein thrombosis |
| Medical professional societies (n = 9) | ||||
| Association of Medical Microbiology and Infectious Disease Canada53 | 2016 | Drug management | HIV-1 infected adults | Early antiretroviral therapy for HIV-1 |
| Canadian Academy of Child and Adolescent Psychiatry54 | 2016 | Drug management | Children and adolescents with depression and/or anxiety disorders | Use of SSRIs and SNRIs to manage depression and anxiety |
| Canadian Association for the Study of the Liver55 | 2018 | Screening and drug management | Adults with chronic HCV infection | Management of chronic hepatitis C |
| Canadian Cardiovascular Society56 | 2018 | Drug management | Patients with atrial fibrillation | Management of atrial fibrillation |
| Canadian Ophthalmological Society57 | 2017 | Screening and drug management | Children and adults with type 1 or type 2 diabetes, of all ethnic origins | Screening, diagnosis and management of diabetic retinopathy |
| Canadian Paediatric Society58 | 2018 | Drug management | Children and adolescents | Human papillomavirus vaccination |
| Canadian Rheumatology Association59 | 2018 | Screening and drug management | Children and adults with systemic lupus erythematosus | Assessment and monitoring of systemic lupus erythematosus |
| Canadian Urological Association60 | 2016 | Drug management | Patients with kidney stones | Evaluation and medical management of kidney stones |
| Society of Obstetricians and Gynaecologists of Canada61 | 2018 | Screening and drug management | Pregnant women | Prevention, screening and treatment of toxoplasmosis in pregnancy |
Note: ADHD = attention deficit/hyperactivity disorder, HCV = hepatitis C virus, SNRI = serotonin–norepinephrine reuptake inhibitor, SSRI = selective serotonin reuptake inhibitor.